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Background:  Hypetrophic Cardiomyopathy is the most common genetic cardiac disease that affects cardiac sarcomere, resulting in myocardial 
disarray. Affected patients have an predisposition for malignant ventricular tachyarrythmias and consequently, sudden cardiac death(SCD). In some 
single center studies, late gadolinium enhancement (LGE), defined fibrosis has been linked to the substrate for VT/VF. However, despite innumerables 
investigations, SCD has not been definitely atributtable to LGE. Explanation to this are believed to be related to the insufficient statistical power.
Methods:  We performed an eletronic search for MEDLINE, PUBMED and CMR abstracts for original data published or presented between january 
01 - march 11. Key search terms: HCM, LV fibrosis, SCD and LGE. Studies were screened for eligibility based on very restricted criterias: referral 
for CMR exam with LGE for HCM; and follow up for incidence of VT/VF and SCD. Relevant studies were summarized and the following data were 
abstracted: socio-demographic information; study design; incidence of VT/VF; SCD. Categorical variables were evaluated between patients groups by 
chi-square test.
Results:  A total of 64 studies were initial identified. Of this, 4(6,3%), were identified and included (n= 1063pts, range 202 to 424). 3 prospective 
and 1 retrospective study were included. LGE, was detected in 59,6% of patients. Main follow up was around 43months. Age 22-90 years (63% 
male). As expected, the presence of myocardial fibrosis was associated with VT/VF (X=6.5, p< 0.05; OR= 9.0 95% CI 1.2 to 68.7). Moreover 
myocardial fibrosis strongly predicted SCD (X=6.6, p<0.05; OR 3.3 95% CI 1.2 to 9.7).
Conclusions:  LGE has consistenly predicted VT/VF, and for the first time, we have been able to demonstrate that LGE defined fbrosis is a predictor 
of SCD in patients of HCM.
